mRNA skin cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say

[hotblack]

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with standard treatment alone. That’s according to Moderna and Merck, the two pharmaceutical companies that have collaborated on the experimental cancer vaccine, called intismeran autogene (mRNA-4157 or V940)

Full article at Arstechnica

 

[hotblack]

I’ll have more of a dig to find any relevant papers rather than just articles and press releases and update this post or thread. But it looks like another positive for mRNA vaccines.